{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:17:08Z","timestamp":1790371028886,"version":"4.1.0"},"reference-count":60,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2013,4,16]],"date-time":"2013-04-16T00:00:00Z","timestamp":1366070400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0061882","type":"journal-article","created":{"date-parts":[[2013,4,16]],"date-time":"2013-04-16T21:01:39Z","timestamp":1366146099000},"page":"e61882","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":38,"title":["Lipoxin A4 and 15-Epi-Lipoxin A4 Protect against Experimental Cerebral Malaria by Inhibiting IL-12\/IFN-\u03b3 in the Brain"],"prefix":"10.1371","volume":"8","author":[{"given":"Nathaniel","family":"Shryock","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cortez","family":"McBerry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa Maria","family":"Salazar Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Janes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio T. M.","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Aliberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,4,16]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S1474-4422(05)70247-7","article-title":"Pathogenesis, clinical features, and neurological outcome of cerebral malaria","volume":"4","author":"R Idro","year":"2005","journal-title":"Lancet Neurol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0140-6736(05)67176-0","article-title":"Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial","volume":"366","author":"A Dondorp","year":"2005","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"e92","DOI":"10.1542\/peds.2007-3709","article-title":"Cerebral malaria in children is associated with long-term cognitive impairment","volume":"122","author":"CC John","year":"2008","journal-title":"Pediatrics"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"198","DOI":"10.4269\/ajtmh.2008.78.198","article-title":"Cerebrospinal fluid cytokine levels and cognitive impairment in cerebral malaria","volume":"78","author":"CC John","year":"2008","journal-title":"Am J Trop Med Hyg"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/S0140-6736(10)61924-1","article-title":"Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial","volume":"376","author":"AM Dondorp","year":"2010","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"968","DOI":"10.4049\/jimmunol.1200688","article-title":"IFN-gamma-producing CD4+ T cells promote experimental cerebral malaria by modulating CD8+ T cell accumulation within the brain","volume":"189","author":"A Villegas-Mendez","year":"2012","journal-title":"J Immunol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.4049\/jimmunol.1101978","article-title":"IL-12Rbeta2 is essential for the development of experimental cerebral malaria","volume":"188","author":"M Fauconnier","year":"2012","journal-title":"J Immunol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1093\/infdis\/jir656","article-title":"Blood-stage Plasmodium berghei infection generates a potent, specific CD8+ T-cell response despite residence largely in cells lacking MHC I processing machinery","volume":"204","author":"LS Lau","year":"2011","journal-title":"J Infect Dis"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.4049\/jimmunol.1100241","article-title":"Heterogeneous and tissue-specific regulation of effector T cell responses by IFN-gamma during Plasmodium berghei ANKA infection","volume":"187","author":"A Villegas-Mendez","year":"2011","journal-title":"J Immunol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"e18720","DOI":"10.1371\/journal.pone.0018720","article-title":"CD8+ T cells and IFN-gamma mediate the time-dependent accumulation of infected red blood cells in deep organs during experimental cerebral malaria","volume":"6","author":"C Claser","year":"2011","journal-title":"PLoS One"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"e1000369","DOI":"10.1371\/journal.ppat.1000369","article-title":"IP-10-mediated T cell homing promotes cerebral inflammation over splenic immunity to malaria infection","volume":"5","author":"CQ Nie","year":"2009","journal-title":"PLoS Pathog"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1365-3024.2008.01053.x","article-title":"Control of pathogenic CD8+ T cell migration to the brain by IFN-gamma during experimental cerebral malaria","volume":"30","author":"E Belnoue","year":"2008","journal-title":"Parasite Immunol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1002\/1521-4141(200006)30:6<1646::AID-IMMU1646>3.0.CO;2-0","article-title":"Involvement of IFN-gamma receptor-medicated signaling in pathology and anti-malarial immunity induced by Plasmodium berghei infection","volume":"30","author":"V Amani","year":"2000","journal-title":"Eur J Immunol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/eji.1830270403","article-title":"Interferon-gamma is essential for the development of cerebral malaria","volume":"27","author":"W Rudin","year":"1997","journal-title":"Eur J Immunol"},{"key":"ref15","first-page":"257","article-title":"Resistance to cerebral malaria in tumor necrosis factor-alpha\/beta-deficient mice is associated with a reduction of intercellular adhesion molecule-1 up-regulation and T helper type 1 response","volume":"150","author":"W Rudin","year":"1997","journal-title":"Am J Pathol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"5572","DOI":"10.1073\/pnas.86.14.5572","article-title":"Monoclonal antibody against interferon gamma can prevent experimental cerebral malaria and its associated overproduction of tumor necrosis factor","volume":"86","author":"GE Grau","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.neulet.2011.01.038","article-title":"Anxiety-like behavior and proinflammatory cytokine levels in the brain of C57BL\/6 mice infected with Plasmodium berghei (strain ANKA)","volume":"491","author":"AS de Miranda","year":"2011","journal-title":"Neurosci Lett"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"e2608","DOI":"10.1371\/journal.pone.0002608","article-title":"Both functional LTbeta receptor and TNF receptor 2 are required for the development of experimental cerebral malaria","volume":"3","author":"D Togbe","year":"2008","journal-title":"PLoS One"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1084\/jem.20020128","article-title":"Locally up-regulated lymphotoxin alpha, not systemic tumor necrosis factor alpha, is the principle mediator of murine cerebral malaria","volume":"195","author":"CR Engwerda","year":"2002","journal-title":"J Exp Med"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/BF01615662","article-title":"Experimental cerebral malaria: possible new mechanisms in the TNF-induced microvascular pathology","volume":"40","author":"GE Grau","year":"1995","journal-title":"Soz Praventivmed"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"4811","DOI":"10.4049\/jimmunol.151.9.4811","article-title":"Profiles of cytokine production in relation with susceptibility to cerebral malaria","volume":"151","author":"S de Kossodo","year":"1993","journal-title":"J Immunol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1126\/science.3306918","article-title":"Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria","volume":"237","author":"GE Grau","year":"1987","journal-title":"Science"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"135ra164","DOI":"10.1126\/scitranslmed.3003515","article-title":"Effective adjunctive therapy by an innate defense regulatory peptide in a preclinical model of severe malaria","volume":"4","author":"AH Achtman","year":"2012","journal-title":"Sci Transl Med"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"e27714","DOI":"10.1371\/journal.pone.0027714","article-title":"Inhaled nitric oxide reduces endothelial activation and parasite accumulation in the brain, and enhances survival in experimental cerebral malaria","volume":"6","author":"L Serghides","year":"2011","journal-title":"PLoS One"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"513865","DOI":"10.1155\/2012\/513865","article-title":"The Case for the Use of PPARgamma Agonists as an Adjunctive Therapy for Cerebral Malaria","volume":"2012","author":"L Serghides","year":"2012","journal-title":"PPAR Res"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1586\/eri.10.90","article-title":"Adjunctive therapy for cerebral malaria and other severe forms of Plasmodium falciparum malaria","volume":"8","author":"CC John","year":"2010","journal-title":"Expert Rev Anti Infect Ther"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/CCM.0b013e3181958dfd","article-title":"N-acetylcysteine as adjunctive treatment in severe malaria: a randomized, double-blinded placebo-controlled clinical trial","volume":"37","author":"P Charunwatthana","year":"2009","journal-title":"Crit Care Med"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.actatropica.2008.02.001","article-title":"Artesunate-erythropoietin combination for murine cerebral malaria treatment","volume":"106","author":"AL Bienvenu","year":"2008","journal-title":"Acta Trop"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4269\/ajtmh.77.6.suppl.29","article-title":"The management of patients with severe malaria","volume":"77","author":"N Day","year":"2007","journal-title":"Am J Trop Med Hyg"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1073\/pnas.0706867105","article-title":"Protection against cerebral malaria by the low-molecular-weight thiol pantethine","volume":"105","author":"MF Penet","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/01.qco.0000180161.38530.81","article-title":"The relevance of malaria pathophysiology to strategies of clinical management","volume":"18","author":"T Planche","year":"2005","journal-title":"Curr Opin Infect Dis"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"e1002401","DOI":"10.1371\/journal.ppat.1002401","article-title":"The role of animal models for research on severe malaria","volume":"8","author":"AG Craig","year":"2012","journal-title":"PLoS Pathog"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ijpara.2006.02.007","article-title":"Pathogenic T cells in cerebral malaria","volume":"36","author":"L Renia","year":"2006","journal-title":"Int J Parasitol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.pt.2010.03.006","article-title":"Murine cerebral malaria: the whole story","volume":"26","author":"NH Hunt","year":"2010","journal-title":"Trends Parasitol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S1471-4906(03)00229-1","article-title":"Cytokines: accelerators and brakes in the pathogenesis of cerebral malaria","volume":"24","author":"NH Hunt","year":"2003","journal-title":"Trends Immunol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"629","DOI":"10.2174\/1568026611109060629","article-title":"Novel anti-inflammatory--pro-resolving mediators and their receptors","volume":"11","author":"CN Serhan","year":"2011","journal-title":"Curr Top Med Chem"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1146\/annurev.immunol.25.022106.141647","article-title":"Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways","volume":"25","author":"CN Serhan","year":"2007","journal-title":"Annu Rev Immunol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/ni745","article-title":"Lipoxin-mediated inhibition of IL-12 production by DCs: a mechanism for regulation of microbial immunity","volume":"3","author":"J Aliberti","year":"2002","journal-title":"Nat Immunol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1084\/jem.20021183","article-title":"Parasite-induced lipoxin A4 is an endogenous regulator of IL-12 production and immunopathology in Toxoplasma gondii infection","volume":"196","author":"J Aliberti","year":"2002","journal-title":"J Exp Med"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1172\/JCI23949","article-title":"Host control of Mycobacterium tuberculosis is regulated by 5-lipoxygenase-dependent lipoxin production","volume":"115","author":"A Bafica","year":"2005","journal-title":"J Clin Invest"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1093\/hmg\/ddm378","article-title":"ALOX5 variants associated with susceptibility to human pulmonary tuberculosis","volume":"17","author":"F Herb","year":"2008","journal-title":"Hum Mol Genet"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.prostaglandins.2006.10.003","article-title":"Aspirin augments 15-epi-lipoxin A4 production by lipopolysaccharide, but blocks the pioglitazone and atorvastatin induction of 15-epi-lipoxin A4 in the rat heart","volume":"83","author":"Y Birnbaum","year":"2007","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1161\/CIRCULATIONAHA.106.629907","article-title":"Augmentation of myocardial production of 15-epi-lipoxin-a4 by pioglitazone and atorvastatin in the rat","volume":"114","author":"Y Birnbaum","year":"2006","journal-title":"Circulation"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"14609","DOI":"10.1021\/bi00044a041","article-title":"Design of lipoxin A4 stable analogs that block transmigration and adhesion of human neutrophils","volume":"34","author":"CN Serhan","year":"1995","journal-title":"Biochemistry"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1042\/BST0390994","article-title":"Deficient expression of bactericidal\/permeability-increasing protein in immunocompromised hosts: translational potential of replacement therapy","volume":"39","author":"CD Palmer","year":"2011","journal-title":"Biochem Soc Trans"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/SHK.0b013e31822798c1","article-title":"Lipoxin a4 increases survival by decreasing systemic inflammation and bacterial load in sepsis","volume":"36","author":"J Walker","year":"2011","journal-title":"Shock"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nri1547","article-title":"Host persistence: exploitation of anti-inflammatory pathways by Toxoplasma gondii","volume":"5","author":"J Aliberti","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"e38384","DOI":"10.1371\/journal.pone.0038384","article-title":"SOCS2-induced proteasome-dependent TRAF6 degradation: a common anti-inflammatory pathway for control of innate immune responses","volume":"7","author":"C McBerry","year":"2012","journal-title":"PLoS One"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/nature05877","article-title":"Resolvin E1 and protectin D1 activate inflammation-resolution programmes","volume":"447","author":"JM Schwab","year":"2007","journal-title":"Nature"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1172\/JCI1578","article-title":"Neutrophil-mediated changes in vascular permeability are inhibited by topical application of aspirin-triggered 15-epi-lipoxin A4 and novel lipoxin B4 stable analogues","volume":"101","author":"T Takano","year":"1998","journal-title":"J Clin Invest"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"6972","DOI":"10.1074\/jbc.272.11.6972","article-title":"Lipoxin A4 stable analogs are potent mimetics that stimulate human monocytes and THP-1 cells via a G-protein-linked lipoxin A4 receptor","volume":"272","author":"JF Maddox","year":"1997","journal-title":"J Biol Chem"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1586\/eri.11.96","article-title":"Immunopathogenesis of falciparum malaria: implications for adjunctive therapy in the management of severe and cerebral malaria","volume":"9","author":"SJ Higgins","year":"2011","journal-title":"Expert Rev Anti Infect Ther"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1164\/rccm.200905-0786OC","article-title":"Immunopathology and dexamethasone therapy in a new model for malaria-associated acute respiratory distress syndrome","volume":"181","author":"PE Van den Steen","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"ref54","article-title":"Steroids for treating cerebral malaria","author":"K Prasad","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"ref55","first-page":"59","article-title":"Cerebral malaria in children. Comparative study between heparin, dexamethasone and placebo","volume":"31","author":"TH Rampengan","year":"1991","journal-title":"Paediatr Indones"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/infdis\/158.2.325","article-title":"High-dose dexamethasone in quinine-treated patients with cerebral malaria: a double-blind, placebo-controlled trial","volume":"158","author":"SL Hoffman","year":"1988","journal-title":"J Infect Dis"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1093\/infdis\/158.2.320","article-title":"Steroids are out in the treatment of cerebral malaria: what&apos;s next?","volume":"158","author":"DJ Wyler","year":"1988","journal-title":"J Infect Dis"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/S0140-6736(00)04982-5","article-title":"Salicylates, nitric oxide, malaria, and Reye&apos;s syndrome","volume":"357","author":"ML Willcox","year":"2001","journal-title":"Lancet"},{"key":"ref59","first-page":"617","article-title":"Purpura fulminans in a patient with malaria","volume":"10","author":"JE Keri","year":"2000","journal-title":"Eur J Dermatol"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.4049\/jimmunol.0900477","article-title":"Effects of low-dose aspirin on acute inflammatory responses in humans","volume":"183","author":"T Morris","year":"2009","journal-title":"J Immunol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0061882","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T02:12:52Z","timestamp":1688177572000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0061882"}},"subtitle":[],"editor":[{"given":"Georges","family":"Snounou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,4,16]]},"references-count":60,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2013,4,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0061882","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,16]]}}}